readthroughSign in
CompanyPRMENasdaqCambridge, MA

Prime Medicine, Inc.

Prime Medicine develops Prime Editing, a gene editing technology for targeted DNA modifications without double-stranded breaks.

10-QSep 2Latest SEC filing, period to Jun 30
Aug 6Latest story